Low impact
Gilead Sciences is launching four drugs this year, which may change investor perception that it is solely an HIV-focused company.
Finnhub07/12, 08:43 PM
- 4 Drug Launches This Year
Figures as quoted by Finnhub
Related assets
Coming up for GILD
Explore next
Latest GILD news
Jin1008/14, 09:47 PM
FirstSquawk08/05, 03:08 AM
FirstSquawk08/05, 03:08 AM